HRP20231470T1 - Terapija za infekcije humanim papilomavirusom visokog rizika - Google Patents

Terapija za infekcije humanim papilomavirusom visokog rizika Download PDF

Info

Publication number
HRP20231470T1
HRP20231470T1 HRP20231470TT HRP20231470T HRP20231470T1 HR P20231470 T1 HRP20231470 T1 HR P20231470T1 HR P20231470T T HRP20231470T T HR P20231470TT HR P20231470 T HRP20231470 T HR P20231470T HR P20231470 T1 HRP20231470 T1 HR P20231470T1
Authority
HR
Croatia
Prior art keywords
use according
pharmaceutical preparation
preparation
patient
acid
Prior art date
Application number
HRP20231470TT
Other languages
English (en)
Croatian (hr)
Inventor
Norbert Fuchs
Original Assignee
Selo Medical Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Selo Medical Gmbh filed Critical Selo Medical Gmbh
Publication of HRP20231470T1 publication Critical patent/HRP20231470T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HRP20231470TT 2018-08-28 2019-08-28 Terapija za infekcije humanim papilomavirusom visokog rizika HRP20231470T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18191289.0A EP3616693A1 (en) 2018-08-28 2018-08-28 Therapy of high-risk human papillomavirus infections
PCT/EP2019/072926 WO2020043762A1 (en) 2018-08-28 2019-08-28 Therapy of high-risk human papillomavirus infections
EP19765421.3A EP3843715B1 (en) 2018-08-28 2019-08-28 Therapy of high-risk human papillomavirus infections

Publications (1)

Publication Number Publication Date
HRP20231470T1 true HRP20231470T1 (hr) 2024-03-01

Family

ID=63442535

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20231470TT HRP20231470T1 (hr) 2018-08-28 2019-08-28 Terapija za infekcije humanim papilomavirusom visokog rizika

Country Status (25)

Country Link
US (2) US20210299163A1 (cg-RX-API-DMAC7.html)
EP (2) EP3616693A1 (cg-RX-API-DMAC7.html)
JP (1) JP7420791B2 (cg-RX-API-DMAC7.html)
CN (1) CN112584828A (cg-RX-API-DMAC7.html)
AR (1) AR116027A1 (cg-RX-API-DMAC7.html)
AU (1) AU2019332079B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021003360A2 (cg-RX-API-DMAC7.html)
CA (1) CA3107691C (cg-RX-API-DMAC7.html)
CL (1) CL2021000197A1 (cg-RX-API-DMAC7.html)
EA (1) EA202190441A1 (cg-RX-API-DMAC7.html)
ES (1) ES2958808T3 (cg-RX-API-DMAC7.html)
GE (2) GEP20227432B (cg-RX-API-DMAC7.html)
HR (1) HRP20231470T1 (cg-RX-API-DMAC7.html)
HU (1) HUE064691T2 (cg-RX-API-DMAC7.html)
IL (1) IL281080B2 (cg-RX-API-DMAC7.html)
MA (1) MA53482B1 (cg-RX-API-DMAC7.html)
MD (1) MD3843715T2 (cg-RX-API-DMAC7.html)
MX (1) MX2021002310A (cg-RX-API-DMAC7.html)
PL (1) PL3843715T3 (cg-RX-API-DMAC7.html)
RS (1) RS64916B1 (cg-RX-API-DMAC7.html)
SM (1) SMT202300340T1 (cg-RX-API-DMAC7.html)
TW (1) TWI827652B (cg-RX-API-DMAC7.html)
UA (1) UA127632C2 (cg-RX-API-DMAC7.html)
WO (1) WO2020043762A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202100375B (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3875083A1 (en) * 2020-03-03 2021-09-08 Selo Medical GmbH Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid
CN113304251A (zh) * 2021-03-04 2021-08-27 南京北极光生物科技有限公司 一种组合物在抗人乳头瘤病毒中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2406377C (en) 2000-05-10 2010-07-06 Okopharm Forschungs-Und Entwicklungs-Gmbh Method for reducing the surface area of silicon dioxide
AT412758B (de) 2000-06-05 2005-07-25 Vis Vitalis Lizenz & Handels Verwendung einer selenithältigen lösung zur behandlung viraler erkrankungen
AT412448B (de) 2001-02-13 2005-03-25 Vis Vitalis Lizenz & Handels Verwendung von selenhältigen präparaten
AT412703B (de) * 2001-12-04 2005-06-27 Vis Vitalis Lizenz & Handels Verwendung von selenithältigen präparaten zur topischen oder bukkalen anwendung
AT511159A1 (de) * 2011-02-16 2012-09-15 Selo Medical Gmbh Pharmazeutische zusammensetzungen enthaltend selenit- oder selenathältige verbindungen

Also Published As

Publication number Publication date
SMT202300340T1 (it) 2023-11-13
IL281080B1 (en) 2024-08-01
EP3843715C0 (en) 2023-09-13
US20250281524A1 (en) 2025-09-11
US20210299163A1 (en) 2021-09-30
JP7420791B2 (ja) 2024-01-23
JP2021536454A (ja) 2021-12-27
PL3843715T3 (pl) 2024-02-19
HUE064691T2 (hu) 2024-04-28
MA53482A (fr) 2021-07-07
IL281080A (en) 2021-04-29
EP3616693A1 (en) 2020-03-04
GEP20227432B (en) 2022-10-25
CN112584828A (zh) 2021-03-30
ZA202100375B (en) 2024-08-28
AU2019332079A1 (en) 2021-02-11
TW202023534A (zh) 2020-07-01
EA202190441A1 (ru) 2021-06-15
MX2021002310A (es) 2021-04-28
MA53482B1 (fr) 2023-11-30
RS64916B1 (sr) 2023-12-29
AU2019332079B2 (en) 2024-08-29
MD3843715T2 (ro) 2023-12-31
EP3843715A1 (en) 2021-07-07
AR116027A1 (es) 2021-03-25
TWI827652B (zh) 2024-01-01
WO2020043762A1 (en) 2020-03-05
UA127632C2 (uk) 2023-11-08
IL281080B2 (en) 2024-12-01
CA3107691C (en) 2024-10-29
GEAP202215586A (en) 2022-06-27
CA3107691A1 (en) 2020-03-05
BR112021003360A2 (pt) 2021-05-11
ES2958808T3 (es) 2024-02-15
CL2021000197A1 (es) 2021-09-20
EP3843715B1 (en) 2023-09-13

Similar Documents

Publication Publication Date Title
CN101254212B (zh) 美洲大蠊提取物有效部位在制备治疗生殖器疱疹药物中的应用
JP2019501108A (ja) 粘膜炎症を抑制するためのイガイ接着タンパク質生成物及びその使用
CN106466454A (zh) 一种预防及治疗妇科炎症的凝胶剂
CN103316262B (zh) 一种妇科外用抗菌液及其制备方法
EP3222283B1 (en) Lentinan for use in the treatment of endometriosis
JP2021536454A5 (cg-RX-API-DMAC7.html)
CN113304251A (zh) 一种组合物在抗人乳头瘤病毒中的应用
CN105748989B (zh) 一种抗菌抗病毒的组合物及其制备方法
RU2557957C1 (ru) Способ лечения больных с хроническим эндометритом и трубно перитонеальным фактором бесплодия
CN103463606B (zh) 一种治疗妇科疾病的药物
CN111991498A (zh) 一种用于治疗hpv的重链抗体复合凝胶及其制备方法
GEP20227432B (en) Therapy of high-risk human papillomavirus infections
CN105213353A (zh) 含有薁磺酸钠的复方口腔膜剂及制备方法
HRP20240374T1 (hr) Pripravak za uporabu u liječenju anomalija cervikalnih stanica koji sadrži spoj selenita i kiselinu
CN104274515A (zh) 一种治疗风热犯肺型咳嗽的中药
CN103611027B (zh) 一种临床预防、护理和治疗滴虫性阴道炎的药物组合物
ITMI20120867A1 (it) Composizione per il trattamento di lesioni.
CN102688330A (zh) 一种生物中药药膜及其制备方法
CN107296859B (zh) 治疗子宫肌瘤的中药制剂及其制备方法
CN113456715B (zh) 一种治疗疱疹病毒感染性皮肤病的中药组合物及制备方法
CN105727211A (zh) 一种治疗人乳头瘤病毒感染的中药栓剂及其制备方法
CN104815151A (zh) 一种治疗温燥伤肺型咳嗽的中药
JP2019507195A5 (cg-RX-API-DMAC7.html)
RU2071773C1 (ru) Лекарственное средство для лечения синдромов приобретенного иммунодефицита, в том числе вич-обусловленных
JP2023516153A5 (cg-RX-API-DMAC7.html)